Liranaftate is a new type of the third generation of glucosinolates carbamate antifungal drugs,manufactured and marketed by Wansheng Pharmaceutical, which we acquired in July, 2015, indicated for the treatment of tinea pedis,tinea corporis,tinea cruris.Compared to traditonal antifungal medication,Liranaftate show better antifungal therapy effect in clinical trials.